Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Herman

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Annals of Clinical and Laboratory Science|November 1, 1976
Toxic cardiomyopathiesT Balazs, E H Herman
Cancer Treatment Reviews|December 1, 1984
Amelioration of antitumour drug toxicityK Hellmann, E H Herman
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|September 1, 1981
[Case of skull perforation by a trammel through the sagittal sinus with brain tissue damage]Z Kabut, E H Herman
Toxicology and Applied Pharmacology|July 1, 1972
Cardiovascular and central nervous system effects of parenterally administered single doses of procarbazine (NSC-77,213)E H Herman, I Lee
Cancer Treatment Reviews|December 1, 1987
Amelioration of chronic anthracycline cardiotoxicity by ICRF-187 and other compoundsE H Herman, V J Ferrans
Cancer Treatment Reports|November 1, 1976
Some cardiovascular effects of cyclocytidineE H Herman, D P Chadwick
Pharmacology|January 1, 1973
A comparison of the cardiovascular actions of thalicarpine and its moietiesE H Herman, D P Chadwick
Cancer Treatment Reviews|September 1, 1990
Examination of the potential long-lasting protective effect of ICRF-187 against anthracycline-induced chronic cardiomyopathyE H Herman, V J Ferrans
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1983
Influence of vitamin E and ICRF-187 on chronic doxorubicin cardiotoxicity in miniature swineE H Herman, V J Ferrans
Cancer Research|September 1, 1981
Reduction of chronic doxorubicin cardiotoxicity in dogs by pretreatment with (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187)E H Herman, V J Ferrans
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Annals of Clinical and Laboratory Science|November 1, 1976
Toxic cardiomyopathiesT Balazs, E H Herman
Cancer Treatment Reviews|December 1, 1984
Amelioration of antitumour drug toxicityK Hellmann, E H Herman
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|September 1, 1981
[Case of skull perforation by a trammel through the sagittal sinus with brain tissue damage]Z Kabut, E H Herman
Toxicology and Applied Pharmacology|July 1, 1972
Cardiovascular and central nervous system effects of parenterally administered single doses of procarbazine (NSC-77,213)E H Herman, I Lee
Cancer Treatment Reviews|December 1, 1987
Amelioration of chronic anthracycline cardiotoxicity by ICRF-187 and other compoundsE H Herman, V J Ferrans
Cancer Treatment Reports|November 1, 1976
Some cardiovascular effects of cyclocytidineE H Herman, D P Chadwick
Pharmacology|January 1, 1973
A comparison of the cardiovascular actions of thalicarpine and its moietiesE H Herman, D P Chadwick
Cancer Treatment Reviews|September 1, 1990
Examination of the potential long-lasting protective effect of ICRF-187 against anthracycline-induced chronic cardiomyopathyE H Herman, V J Ferrans
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1983
Influence of vitamin E and ICRF-187 on chronic doxorubicin cardiotoxicity in miniature swineE H Herman, V J Ferrans
Cancer Research|September 1, 1981
Reduction of chronic doxorubicin cardiotoxicity in dogs by pretreatment with (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187)E H Herman, V J Ferrans
Pageof 9